Material-based engineering of bacteria for cancer diagnosis and therapy
Source abstract
Abstract
Abstract Various categories of biomaterials have been utilized for drug delivery, genetic modification, photodynamic and photothermal therapies due to their distinct physicochemical properties, including photothermal convertibility, stimuli-responsiveness, and inherent capability to generate photodynamical radicals. However, successful treatments of cancer are largely hindered by the limited accessibility of nanomaterials into hypoxic or metastatic tumor tissues. Among the various tumor-targeting strategies, bacterial fabrication exhibits particular advantages such as specific hypoxia tropism, high motility, and rapid self-replication. Biomineralization, i.e. bacterial modification, involves the fabrication of bacteria by nanomaterials for precise cancer imaging as well as targeted drug delivery, overcoming the physiological barriers and improving the therapeutic efficiency. Fabrication of bacteria strains can be conducted by various methods, including direct adsorption, electrostatic interaction, covalent ligation, and surface precipitation. In this review, a brief introduction to commonly-utilized biomaterials and bacteria species is provided. A systemic overview of recent advances of bacteria fabrication strategies and techniques are then discussed, followed by future prospective of bacteria-facilitated cancer therapy and diagnostics.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Cancer Research and Treatments · Nanoplatforms for cancer theranostics · Bacteriophages and microbial interactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. The side effects of platinum-based chemotherapy drugs: a review for chemists10.1039/C8DT00838H ↗
2. Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach10.1016/j.radonc.2013.05.007 ↗
3. Back to the future: are tumor-targeting bacteria the next-generation cancer therapy?10.1007/978-1-4939-2727-2_14 ↗
4. The role of bacteria in cancer therapy–Enemies in the past, but allies at present10.1186/s13027-018-0180-y ↗
5. Cytotoxic and antitumor-activity of a soluble fraction of streptococcus-pyogenes against s180 sarcoma-cells10.7883/yoken1952.39.169 ↗
6. Bacteria as tumour-targeting vectors10.1016/S1470-2045(03)01194-X ↗
7. Bacteria in cancer therapy: a novel experimental strategy10.1186/1423-0127-17-21 ↗
8. Commensal Bacteria control cancer response to therapy by modulating the tumor microenvironment10.1126/science.1240527 ↗
9. E.G. Di Domenico, I. Cavallo, M. Pontone, L. Toma, F. Ensoli, Biofilm producing Salmonella typhi: chronic colonization and development of gallbladder cancer, Int. J. Mol. Sci. 18(9) (2017) 1887. 10.3390/ijms18091887.10.3390/ijms18091887 ↗
10. Gut Microbiota, Inflammation, and Colorectal Cancer10.1146/annurev-micro-102215-095513 ↗
11. Gut mucosal microbiome across stages of colorectal carcinogenesis10.1038/ncomms9727 ↗
12. Gut microbiota modulation of chemotherapy efficacy and toxicity10.1038/nrgastro.2017.20 ↗
13. Early relapse on adjuvant gemcitabine associated with an exceptional response to 2nd line capecitabine chemotherapy in a patient with pancreatic adenosquamous carcinoma with strong intra-tumoural expression of cytidine deaminase: a case report10.1186/s12885-020-6516-1 ↗
14. Gene therapy based on cytidine deaminase-targeting overcomes pancreatic cancer resistance to chemotherapy
15. Prevention of recurrence with epirubicin and Lactobacillus casei after transurethral resection of bladder cancer10.1016/j.juro.2007.09.031 ↗
16. Modulation of pulmonary microbiota by antibiotic or probiotic aerosol therapy: a strategy to promote immunosurveillance against lung metastases10.1016/j.celrep.2018.08.090 ↗
17. Clostridium novyi-NT in cancer therapy10.1016/j.gendis.2016.01.003 ↗
18. Targeted Cancer Therapy Using Engineered Salmonella typhimurium10.4068/cmj.2016.52.3.173 ↗
19. Tumor-targeting therapy using gene-engineered anaerobic-nonpathogenic Bifidobacterium longum10.1007/978-1-4939-3515-4_5 ↗
20. Nissle 1917-derived minicells for targeted delivery of chemotherapeutic drug to hypoxic regions for cancer therapy10.7150/thno.21575 ↗
21. Novel nanomaterial-organism hybrids with biomedical potential10.1002/wnan.1706 ↗
22. Microencapsulation of bacteria: a review of different technologies and their impact on the probiotic effects10.1016/j.ifset.2014.09.010 ↗
23. Electric field effect in atomically thin carbon films10.1126/science.1102896 ↗
24. Biodegradable black phosphorus-based nanospheres for in vivo photothermal cancer therapy10.1038/ncomms12967 ↗
25. Synergistic photothermal and chemical therapy by smart dual-functional graphdiyne nanosheets for treatment of Parkinson's disease
26. Two-dimensional antimonene-based photonic nanomedicine for cancer theranostics
27. Ultrathin 2D nonlayered tellurium nanosheets: facile liquid-phase exfoliation, characterization, and photoresponse with high performance and enhanced stability
28. A novel top-down synthesis of ultrathin 2D Boron nanosheets for multimodal imaging-guided cancer therapy
29. Sub-200 fs soliton mode-locked fiber laser based on bismuthene saturable absorber10.1364/OE.26.022750 ↗
30. Ultrasensitive detection of miRNA with an antimonene-based surface plasmon resonance sensor10.1038/s41467-018-07947-8 ↗
31. Broadband nonlinear photoresponse of 2D TiS2 for ultrashort pulse generation and all-optical thresholding devices
32. Simultaneous voltammetric determination of acetaminophen and isoniazid using MXene modified screen-printed electrode10.1016/j.bios.2019.01.043 ↗
33. An All-Optical, Actively Q-Switched Fiber Laser by an Antimonene-Based Optical Modulator
34. 2D Tellurium based high-performance all-optical nonlinear photonic devices10.1002/adfm.201806346 ↗
35. Few-layer bismuthene for ultrashort pulse generation in a dissipative system based on an evanescent field10.1039/C8NR03068E ↗
36. Many-body complexes in 2D semiconductors10.1002/adma.201706945 ↗
37. Emerging 2D materials beyond graphene for ultrashort pulse generation in fiber lasers10.1039/C8NR09368G ↗
38. 2D black phosphorus saturable absorbers for ultrafast photonics
39. Self-standing polypyrrole/black phosphorus laminated film: promising electrode for flexible supercapacitor with enhanced capacitance and cycling stability10.1021/acsami.7b15458 ↗
40. All-optical phosphorene phase modulator with enhanced stability under ambient conditions10.1002/lpor.201800016 ↗
41. Ultrasmall bismuth quantum dots: facile liquid-phase exfoliation, characterization, and application in high-performance UV-Vis photodetector10.1021/acsphotonics.7b01211 ↗
42. Facile fabrication and characterization of two-dimensional bismuth(III) sulfide nanosheets for high-performance photodetector applications under ambient conditions10.1039/C7NR09046C ↗
43. Ultra-Small 2D PbS nanoplatelets: liquid-phase exfoliation and emerging applications for photo-electrochemical photodetectors10.1002/smll.202005913 ↗
44. PbSe nanocrystals produced by facile liquid phase exfoliation for efficient UV–Vis photodetectors10.1002/adfm.202010401 ↗
45. High-performance photo-electrochemical photodetector based on liquid-exfoliated few-layered inse nanosheets with enhanced stability10.1002/adfm.201705237 ↗
46. Omnipotent phosphorene: a next-generation, two-dimensional nanoplatform for multidisciplinary biomedical applications10.1039/C8CS00342D ↗
47. 2D Black phosphorus-based biomedical applications10.1002/adfm.201808306 ↗
48. Photothermal cancer immunotherapy by erythrocyte membrane-coated black phosphorus formulation10.1016/j.jconrel.2019.01.027 ↗
49. Biocompatible and biodegradable inorganic nanostructures for nanomedicine: silicon and black phosphorus10.1016/j.nantod.2019.02.012 ↗
50. Black phosphorous/indium selenide photoconductive detector for visible and near-infrared light with high sensitivity
51. Conceptually novel black phosphorus/cellulose hydrogels as promising photothermal agents for effective cancer therapy
52. MXene: a promising transition metal carbide anode for lithium-ion batteries10.1016/j.elecom.2012.01.002 ↗
53. Emerging two-dimensional monoelemental materials (Xenes) for biomedical applications10.1039/C8CS00823J ↗
54. Hetero-MXenes: theory, synthesis, and emerging applications10.1002/adma.202004129 ↗
55. MXene/polymer membranes: synthesis, properties, and emerging applications10.1021/acs.chemmater.9b04408 ↗
56. Two-Dimensional MXene (Ti3C2)-integrated cellulose hydrogels: toward smart three-dimensional network nanoplatforms exhibiting light-induced swelling and bimodal photothermal/chemotherapy anticancer activity10.1021/acsami.8b08314 ↗
57. MXene-enabled electrochemical microfluidic biosensor: applications toward multicomponent continuous monitoring in whole blood10.1002/adfm.201807326 ↗
58. The chemistry and applications of metal-organic frameworks10.1126/science.1230444 ↗
59. Ultrathin metal-organic framework: an emerging broadband nonlinear optical material for ultrafast photonics10.1002/adom.201800561 ↗
60. Multifunctional metal-organic framework catalysts: synergistic catalysis and tandem reactions10.1039/C6CS00250A ↗
61. Nanocrystalline titanium metal-organic frameworks for highly efficient and flexible perovskite solar cells10.1021/acsnano.8b02079 ↗
62. Metal-organic frameworks (MOFs) for the removal of emerging contaminants from aquatic environments10.1016/j.ccr.2018.10.003 ↗
63. Synthesis, functionalization, and applications of metal-organic frameworks in biomedicine10.1039/C7DT04116K ↗
64. Metal organic framework top-down and bottom-up patterning techniques10.1039/D0DT02207A ↗
65. The Applications of Metal-Organic Frameworks in Electrochemical Sensors10.1002/celc.201700931 ↗
66. Biodegradable synthetic polymers: preparation, functionalization and biomedical application10.1016/j.progpolymsci.2011.06.004 ↗
67. PLGA-based nanoparticles: a new paradigm in biomedical applications10.1016/j.trac.2015.06.014 ↗
68. PLGA-based nanoparticles as cancer drug delivery systems, Asian Pac
69. Biophysical characterization of PEI/DNA complexes10.1002/jps.10437 ↗
70. Cytoplasm-responsive delivery systems for siRNA using cell-penetrating peptide nanomicelles10.1016/S1773-2247(14)50001-9 ↗
71. Bioreducible poly(amido amine) copolymers derived from histamine and agmatine for highly efficient gene delivery10.1002/pi.5728 ↗
72. Investigation of CaCO3 scale inhibition by PAA, ATMP and PAPEMP10.1016/j.desal.2007.08.006 ↗
73. Immune-instructive polymers control macrophage phenotype and modulate the foreign body response in vivo10.1016/j.matt.2020.03.018 ↗
74. Polyglycidol-stabilized nanoparticles as a promising alternative to nanoparticle PEGylation: polymer synthesis and protein fouling considerations10.1021/acs.langmuir.9b03687 ↗
75. PEGylation Technology in nanomedicine
76. Synthesis and solution self-assembly properties of cyclic rod–Coil diblock copolymers10.1021/acsmacrolett.9b00747 ↗
77. Dendrimers in drug delivery and targeting: drug-dendrimer interactions and toxicity issues10.4103/0975-7406.130965 ↗
78. Nanoparticle self-assembly: from interactions in suspension to polymer nanocomposites10.1039/C8SM00430G ↗
79. A cationic prodrug/therapeutic gene nanocomplex for the synergistic treatment of tumors10.1016/j.biomaterials.2011.03.022 ↗
80. Recent advances in polymeric micelles for anti-cancer drug delivery10.1016/j.ejps.2015.12.031 ↗
81. Phosphoinositides in cell regulation and membrane dynamics10.1038/nature05185 ↗
82. Liposome: classification, preparation, and applications10.1186/1556-276X-8-102 ↗
83. Modeling the proton sponge hypothesis: examining proton sponge effectiveness for enhancing intracellular gene delivery through multiscale modeling10.1080/09205063.2012.690282 ↗
84. Evolution of peptidoglycan biosynthesis under the selective pressure of antibiotics in Gram-positive bacteria10.1111/j.1574-6976.2007.00097.x ↗
85. A facile protocol for the immobilisation of vesicles, virus particles, bacteria, and yeast cells10.1039/c2ib20181j ↗
86. Construction and evaluation of bacteria-driven liposome10.1016/j.snb.2013.03.127 ↗
87. Photosensitiser-gold nanoparticle conjugates for photodynamic therapy of cancer10.1039/c8pp00271a ↗
88. Recent advances in gold and silver nanoparticle based therapies for lung and breast cancers10.1016/j.ijpharm.2018.10.048 ↗
89. Mesoporous platinum nanoparticle-based nanoplatforms for combined chemo-photothermal breast cancer therapy10.1016/j.jcis.2020.02.051 ↗
90. Palladium porphyrin complexes for photodynamic cancer therapy: effect of porphyrin units and metal10.1039/c9pp00363k ↗
91. Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment10.1002/wnan.1449 ↗
92. Tartrate as a substitute of citrate to prepare gold colloids from chloroauric acid10.1016/j.colsurfa.2017.09.017 ↗
93. Parallel multiparameter study of pei-functionalized gold nanoparticle synthesis for biomedical applications: part 2. Elucidating the role of surface chemistry and polymer structure in performance10.1021/acs.langmuir.0c02630 ↗
94. Shape control in gold nanoparticle synthesis10.1039/b711490g ↗
95. Silver as antibacterial agent: ion, nanoparticle, and metal10.1002/anie.201205923 ↗
96. Silver nanoparticle applications and human health10.1016/j.cca.2010.08.016 ↗
97. The next generation of platinum drugs: targeted Pt(II) agents, nanoparticle delivery, and Pt(IV) prodrugs10.1021/acs.chemrev.5b00597 ↗
98. Cisplatin: mode of cytotoxic action and molecular basis of resistance10.1038/sj.onc.1206933 ↗
99. Trifolium-like platinum nanoparticle-mediated photothermal therapy inhibits tumor growth and osteolysis in a bone metastasis model10.1002/smll.201403315 ↗
100. Palladium-catalyzed cross-coupling: a historical contextual perspective to the 2010 Nobel Prize10.1002/anie.201107017 ↗